Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24292943 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24292942 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24292670 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24759897 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24292673 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24292668 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24292672 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24292598 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24292892 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 | |
| SCHEMBL24292945 | 0.98 | MEN1 (0.44) | TSHRMAPK1MEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220401364-A1 | COMPOSITIONS OF FLUOROCARBON NANOEMULSION, AND METHODS OF PREPARATION AND USE THEREOF | NUVOX PHARMA LLC (US) | 2022-12-22 | — | — | US | disclosed |
| CN-110177687-B | Optical film, front panel, image display device, mirror, resistive touch panel, and capacitive touch panel | 富士胶片株式会社 | 2022-06-03 | — | — | CN | disclosed |
| US-11304899-B2 | Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof | NUVOX PHARMA LLC (US) | 2022-04-19 | — | — | US | disclosed |
| CN-112585527-A | Liquid crystal panel and image display device | 富士胶片株式会社 | 2021-03-30 | — | — | CN | disclosed |
| CN-108367560-B | Decorative film, image display device, touch panel, and method for manufacturing decorative film | 富士胶片株式会社 | 2021-02-19 | — | — | CN | disclosed |
| CN-107207753-B | Hard coat film, polarizing plate, liquid crystal display device, and method for producing hard coat film | 富士胶片株式会社 | 2020-12-25 | — | — | CN | disclosed |
| CN-112041714-A | Optical film, polarizing plate, liquid crystal panel, touch panel, and image display device | 富士胶片株式会社 | 2020-12-04 | — | — | CN | disclosed |
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | FUJIFILM CORPORATION (JP) | 2009-11-05 | — | — | US | disclosed |
| EP-0701986-B1 | Process for production of unsaturated ether and catalyst used for production of unsaturated ether | NIPPON CATALYTIC CHEM IND (JP) | 1997-12-29 | — | — | EP | disclosed |
| US-5650544-A | Process for production of unsaturated ether and catalyst used for production of unsaturated ether | NIPPON SHOKUBAI CO., LTD. (JP) | 1997-07-22 | — | — | US | disclosed |
| EP-0701986-A1 | Process for production of unsaturated ether and catalyst used for production of unsaturated ether | NIPPON SHOKUBAI CO., LTD. (JP) | 1996-03-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220401364-A1 | COMPOSITIONS OF FLUOROCARBON NANOEMULSION, AND METHODS OF PREPARATION AND USE THEREOF | PHOSPHO1, SGMS2, SGMS1 | TSHR 4361/4885MAPK1 4853/4885MEN1 4662/4885 |
| US-11304899-B2 | Compositions of fluorocarbon nanoemulsion, and methods of preparation and use thereof | PHOSPHO1, SGMS2, SGMS1 | TSHR 4361/4885MAPK1 4853/4885MEN1 4662/4885 |
| US-20090274853-A1 | DICHROIC DYE COMPOSITION | C1S, CDY1; CDY1B, CRY1 | TSHR 2259/4885MAPK1 1594/4885MEN1 270/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.